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Abstract 1 
Alphaviruses are comprised of a nucleocapsid core surrounded by a lipid membrane 2 
containing glycoprotein spikes.  Previous work demonstrated that in vitro assembled 3 
core-like particles are similar in structure to the nucleocapsid core in the native virus.  4 
Here we demonstrate that in vitro assembled core-like particles can be inserted into 5 
viral glycoprotein-expressing cells to generate enveloped virus-like particles.  These 6 
virus-like particles bud from cells like native virus, are similar in size to the native virus, 7 
and can enter cells to release the contents of the core-like particle into the cytoplasm of 8 
the cell.  Virus-like particles can be used to infect cells with biological and non-biological 9 
cargoes. The generation of enveloped virus-like particles containing an in vitro core and 10 
in vivo synthesized glycoproteins has applications for gene and drug delivery, medical 11 
imaging, and also basic mechanistic studies of virus assembly. 12 
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Introduction 1 
Alphaviruses are simple, enveloped viruses with a positive-sense RNA genome 2 
(Strauss and Strauss, 1994).  The particle is ~70 nm in diameter and has three 3 
concentric layers:  a central nucleocapsid core that consists of the viral genome 4 
surrounded by the capsid protein, a host-derived lipid membrane that covers the core, 5 
and, on the surface of the particle, 80 trimeric glycoprotein spikes that are embedded in 6 
the lipid membrane (Cheng et al., 1995; Mukhopadhyay et al., 2006). 7 
Alphavirus particle assembly consists of two parallel and independent pathways, 8 
nucleocapsid core and glycoprotein spike formation.  The two pathways merge during 9 
budding, the final stage of virus assembly.  The five structural proteins, capsid-E3-E2-10 
6K-E1, are synthesized from a 26s subgenomic mRNA.  The capsid protein is 11 
autoproteolytically cleaved from the polyprotein during translation (Melancon and 12 
Garoff, 1987).  In the cytoplasm, 240 capsid proteins and one progeny genome self-13 
assemble to form a nucleocapsid core.  The remainder of the polyprotein, E3-E2-6K-E1, 14 
is co-translationally translocated into the ER where it is cleaved into individual proteins.  15 
Spikes are assembled in the ER and Golgi, and transported to the plasma membrane 16 
via the host cell secretory machinery (Wahlberg, Boere, and Garoff, 1989; Ziemiecki, 17 
Garoff, and Simons, 1980).  During budding, the nucleocapsid core protrudes through 18 
the cell membrane embedded with glycoprotein spikes and a virus particle is released 19 
from the cell.  It is hypothesized that the interaction between the cytoplasmic tail of the 20 
E2 protein and the hydrophobic pocket in the capsid protein aids in assembly and 21 
stabilizes the virus particle (Lee et al., 1996; Skoging et al., 1996; Wilkinson et al., 2005; 22 
Zhao et al., 1994).  Mutations in the E2 cytoplasmic tail inhibited virus budding and 23 
 4 
reduced particle formation (Owen and Kuhn, 1997; West and Brown, 2006).  While the 1 
amino acid sequence of E2 cytoplasmic tails are similar (Lee et al., 1996; Skoging et al., 2 
1996), chimeric viruses where the glycoproteins are from one alphavirus species and 3 
the capsid is from another species, form very low levels of particles compared to the 4 
parental viruses (Lopez et al., 1994).  Non-enveloped nucleocapsid cores are not 5 
released from cells.  The distinct and separable assembly pathways make alphaviruses 6 
an attractive system for synthesizing enveloped virus-like particles (VLPs) using in vitro 7 
assembled components.   8 
Alphavirus core-like particles (CLPs) have been assembled in vitro by mixing 9 
recombinant alphavirus capsid protein and single-stranded nucleic acid (Tellinghuisen 10 
et al., 1999).  CLPs can also be assembled using artificial scaffolds such as 11 
nanoparticles (Goicochea et al., 2007) and polyanions such as heparin (F. Cheng and 12 
S. Mukhopadhyay, unpublished data).  Cryo-electron microscopy and 3D image 13 
reconstructions of CLPs containing a DNA oligomer demonstrated that the CLPs are 14 
approximately 40 nm in diameter and that the capsid protein subunits within the CLPs 15 
are arranged with T=4 icosahedral symmetry (Mukhopadhyay et al., 2002): both are 16 
characteristic of wild-type nucleocapsid cores.  However, previous studies of CLPs did 17 
not demonstrate whether or not they could interact with glycoprotein spikes to form 18 
VLPs.   19 
In this study, we show that in vitro assembled alphavirus CLPs can associate with 20 
alphavirus glycoproteins to form enveloped VLPs.  Thus, in vitro assembled CLPs retain 21 
the functionality of nucleocapsid core in the absence of any host chaperones.  As with 22 
native alphaviruses, these in vitro assembled VLPs enter cells via the endocytotic 23 
 5 
pathway.  Furthermore, the VLPs can disassemble and release the contents within the 1 
encapsidated the CLP.   This is the first demonstration that a functional enveloped virus-2 
like particle containing an in vitro assembled core can be synthesized.  The ability to 3 
make VLPs containing different cargos in their CLP has significance for basic 4 
mechanistic studies of virus assembly as well as drug and nucleic acid delivery and 5 
medical imaging applications. 6 
 7 
Results and Discussion 8 
In vitro core-like particles are assembled using different cargoes 9 
Capsid proteins from Sindbis, Western equine encephalitis, and Ross River virus 10 
expressed in E. coli have been shown to assemble into CLPs under similar assembly 11 
conditions (Mukhopadhyay et al., 2002; Tellinghuisen et al., 1999).  We used the Ross 12 
River virus system because full-length capsid protein can be obtained in high yields 13 
from a recombinant bacterial expression system, resulting in the reproducible synthesis 14 
of higher concentrations of CLPs (Mukhopadhyay et al., 2002).  Furthermore, CLPs can 15 
be packaged with a variety of polyanions and both RNA- and DNA-containing CLPs 16 
were used in this work.  Purified CLPs were homogeneous and approximately 40 nm in 17 
diameter like cytoplasmic cores from virus-infected cells and the nucleocapsid core from 18 
virus particles (Figure 1a-c).   Yields of purified CLPs were 30-50% of the starting 19 
capsid protein in numerous independent preparations.   20 
 21 
Functional alphavirus glycoproteins are synthesized in BHK cells 22 
 6 
To create a cell line that transiently expressed surface glycoproteins for enveloping 1 
in vitro assembled CLPs, we cloned the gene fragment encoding the wild-type Ross 2 
River virus E3-E2-6K-E1 proteins into the pCAGGS DNA vector (pRRV-GP) for 3 
transient expression, guided by expression systems previously described (Kondor-4 
Koch, Burke, and Garoff, 1983; Liljestrom and Garoff, 1991).  As a negative control, 5 
pRRV-GP was modified (pRRV-mtGP) so amino acid residues 399-401 of the E2 6 
cytoplasmic tail were mutated from YAL to DDD.  The glycoproteins synthesized from 7 
pRRV-mtGP should not interact with CLPs because the putative hydrophobic interaction 8 
between the E2 cytoplasmic tail and the capsid protein has been disrupted (Owen and 9 
Kuhn, 1997; West et al., 2006; Zhao et al., 1994).  As a second negative control, we 10 
cloned the glycoproteins from wild-type Sindbis virus (pSV-GP) into the pCAGGS vector 11 
to investigate the specificity of RRV CLPs towards other alphavirus glycoproteins.  12 
BHK cells transfected with either pRRV-GP, pRRV-mtGP, or pSV-GP produced 13 
comparable amounts of the E2 protein and its precursor, pE2 (also called p62), as 14 
determined by western blot analysis (data not shown).  The cellular distribution of 15 
glycoproteins from pRRV-GP, pRRV-mtGP, and pSV-GP were similar to each other and 16 
to virus-infected cells (Figure 1d).  Cells transfected with pRRV-GP, pRRV-mtGP, and 17 
pSV-GP could undergo cell-to-cell fusion under low pH conditions (Chanel-Vos and 18 
Kielian, 2004; Hernandez et al., 2003) suggesting the expressed glycoproteins can 19 
mediate membrane fusion, whereas mock transfected cells did not form syncytia at any 20 
pH tested.  These results are consistent with those reported for other alphavirus 21 
systems. 22 
 23 
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Cytoplasmic cores form virus particles with viral glycoproteins produced from 1 
pRRV-GP 2 
In virus-infected cells, cytoplasmic nucleocapsid cores contain the viral genome.  3 
Initially we investigated whether or not we could form infectious particles by transfecting 4 
purified cytoplasmic cores into cells expressing viral glycoproteins from pRRV-GP.  This 5 
approach used assembly components most similar to those found in a virus infection. 6 
We transfected 18 µg, or 1.6x1012 purified cytoplasmic nucleocapsid cores from 7 
Ross River virus-infected cells into 1.4x107 BHK cells previously transfected with pRRV-8 
GP or into non-transfected 1.4x107 BHK control cells.  After one hour cells were washed 9 
and after an additional hour incubation in fresh medium, the latter was collected and 10 
assayed for infectious particles.  The short incubation time minimized the chance of 11 
genome replication and virus assembly from a disassembled cytoplasmic core.  There 12 
were 300-600 pfu (~102 pfu/ml) from pRRV-GP-transfected cells.  In contrast, no 13 
infectious particles were isolated from BHK control cells.  This indicates that cytoplasmic 14 
cores by themselves did not disassemble and could not propagate infections in our time 15 
frame.  The low titer of the infective virus likely reflects a combination of low transfection 16 
efficiency of cytoplasmic cores, the limited transport of cytoplasmic cores to the 17 
appropriate membrane for packaging, and the short time period over which we collected 18 
particles.  Nevertheless, these results show that cells transfected with cytoplasmic cores 19 
can generate infectious virus particles. 20 
 21 
Optimizing the strategy for generating VLPs 22 
 8 
We sought to determine whether in vitro assembled Ross River CLPs could 1 
associate with Ross River glycoproteins expressed in trans to form VLPs.   We first 2 
needed to determine the timing of the transfection of CLPs into BHK cells and timing of 3 
particle budding.  Transfection is highly dependent on the size of the entering particle 4 
and its surface charge.  Although transfection has been successfully used with cores of 5 
other viral systems (Bichko, Netter, and Taylor, 1994; Jiang and Coombs, 2005), it has 6 
not been previously reported for alphavirus nucleocapsid cores.  We determined CLP 7 
transfection by monitoring the presence of capsid protein in newly transfected cells.  We 8 
transfected 3 µg CLPs containing 48mer DNA (~2.6x1011 CLPs) into 2.4x106 non-9 
transfected BHK control cells using Lipofectamine as used with other virus systems.  At 10 
various times post-transfection, the cells were washed and lysed, and the lysates were 11 
then probed for capsid protein by western blotting (Figure 2a).  The capsid protein in 12 
these cells would be from the CLPs that were transfected into them.  The presence of 13 
capsid protein was detected within 15 minutes post-transfection and reached a 14 
maximum at 30-60 minutes post-transfection.  Levels of capsid protein started to 15 
decrease only after 4 hours.  The stability of the capsid protein suggests that CLPs are 16 
not immediately disassembling because during a native alphavirus infection, the 17 
nucleocapsid core disassembles under acidic conditions within 2 minutes of entry into 18 
the cytoplasm (Wengler, 2009; Wengler and Wengler, 2002).  However, in these 19 
transfection assays, CLPs enter the cytoplasm directly and bypasses the endosome 20 
(Jiang and Coombs, 2005).     21 
We hypothesized that the timing of virus-like particle budding would be different than 22 
during a native alphavirus infection because during production of VLPs, the core was 23 
 9 
already assembled and ready to bud.  To determine the timing of potential VLPs being 1 
released into the media, we assayed medium for the presence of capsid protein as an 2 
indicator of VLPs.  We transfected 19 µg CLPs containing 48mer DNA (~1.6x1012 CLPs) 3 
into 1.4x107 BHK cells expressing pRRV-GP.  One hour post-CLP transfection, cells 4 
were washed and fresh medium was added; this is defined as zero time.  Medium from 5 
the cells were collected at 30, 60, and 120 minutes and centrifuged.  Thus, medium 6 
collected at 30 min contains particles released between 0-30 minutes, medium collected 7 
at 60 min contain particles released between 30 and 60 min, and medium collected at 8 
120 min contains particles released between 60 and 120 min.  After centrifugation, each 9 
sample was analyzed for the presence of capsid protein (Figure 2b).  At t=0 no capsid 10 
protein was detected indicating that non-transfected CLPs were completely removed 11 
during the wash step: all capsid protein detected subsequently is therefore from 12 
released VLPs.  We could detect capsid protein in the pelleted particles at 30 min but 13 
between 30 and 60 minutes (time 60 min), much less capsid protein was detected.  14 
These results indicate that virus-like particle assembly and release was complete within 15 
30 minutes of addition of the fresh medium.  One explanation for this narrow time range 16 
for VLP production is that there is a finite number of CLPs inside the viral glycoprotein-17 
expressing cell.  Once all the CLPs form into VLPs, no more particles can be formed.  In 18 
contrast, during a viral infection cytoplasmic cores are continuously being synthesized 19 
so virus particles are continuously being released from the over a long period of time. 20 
In a viral infection, the genome replication and structural protein synthesis occurs 21 
before particle release.  Particles are first detected 4 to 6 hours post-infection and 22 
continue to be released until 12 to 15 hours post-infection.  In our assays, VLPs are 23 
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produced much earlier that virus particles are produced during an infection.  When we 1 
transfect CLPs, we are presumably initiating assembly at the last steps of budding when 2 
the nucleocapsid cores interact with the glycoproteins and were able to form virus 3 
particles more quickly.   The amount of VLPs released depends upon the amount of 4 
CLPs that have been transfected since new CLPs are not being synthesized within the 5 
cell. 6 
Taking into account the above observations, we standardized our protocol for 7 
making VLPs.  Transfect BHK cells with pRRV-GP and, 15 hours later when 8 
glycoprotein synthesis was occurring, transfect purified CLPs into the same cells.  After 9 
one hour, the medium was removed, cells were washed with PBS to remove non-10 
transfected CLPs, and fresh medium added.  After an additional one hour incubation the 11 
medium was collected and analyzed for VLPs.  This timing was used for two reasons.  12 
First, optimal yield of VLPs were obtained one hour post-CLP transfection (as 13 
determined by western blot).  Second, if we collected all the medium post-CLP 14 
transfection and did not wash the cells, non-transfected CLPs remaining in the medium 15 
would interfere with quantitation and characterization of the VLPs.  As a consequence of 16 
the timing of our assays, we may be underestimating the amount of VLPs that are 17 
formed.  Hypothetically, if CLPs enter the cell within 30 minutes and can bud and be 18 
released within 15 minutes, these VLPs would not be collected in our assays.   19 
 20 
VLPs contain viral glycoproteins and capsid protein 21 
Our small scale optimization results, obtained by transfecting CLPs into BHK cells 22 
expressing pRRV-GP, demonstrated that VLPs were released into the media (Figure 23 
 11 
2b).  We wanted to determine if the viral glycoproteins were also present in the VLPs.  1 
We transfected 90 µg CLPs containing 48mer DNA (~7.8x1012 CLPs) into 7.2x107 BHK 2 
cells expressing pRRV-GP and into non-transfected 7.2x107 BHK control cells.  The 3 
medium from each sample (after the appropriate washes) were applied to a sucrose 4 
cushion and centrifuged.  The pellets from pRRV-GP plus CLPs transfection contained 5 
both E2 and capsid protein as determined by western blot (Figure 3a, lane 4).  In 6 
contrast, resuspended pellets from CLPs transfected into control BHK cells contained 7 
neither E2 nor capsid protein (Figure 3a, lane 3).  This result is consistent with our 8 
hypothesis that VLPs only form in the presence of CLPs and viral glycoproteins.  In 9 
addition, it also demonstrated that non-transfected CLPs were removed during the wash 10 
step.  As a positive control, Ross River virus was pelleted and 1.5x108 particles were 11 
loaded on the gel (Figure 3a, lane 2).   12 
 13 
Virus-like particle formation requires E2-capsid interaction 14 
The interaction between the cytoplasmic tail of the E2 protein and the hydrophobic 15 
pocket of the capsid protein promotes virus budding.  We abolished this interaction 16 
when expressing an E2 mutant (pRRV-mtGP) in which residues in the cytoplasmic tail 17 
were mutated from YAL to DDD.  Glycoprotein expression and syncytia formation for 18 
pRRV-mGP was comparable to cells expressing pRRV-GP and virus-infected cells.  19 
However when 108 µg CLPs containing 48mer DNA oligomer (~9.3x1012 CLPs) into 20 
7.2x107 BHK cells expressing pRRV-mtGP, neither E2 nor capsid protein was detected 21 
(Figure 3b) in the resuspended pellet.  If any VLPs formed with the mutant glycoprotein 22 
pRRV-mtGP, their amounts were severely reduced in comparison to those formed using 23 
 12 
pRRV-GP.  When the YAL->DDD mutation was made in Ross River virus, no infectious 1 
particles were detected in plaque assays.  Thus, VLPs contain E2, capsid protein and 2 
show an E2-capsid protein-dependent interaction.   3 
 4 
VLPs are morphologically similar to native virus particles 5 
We wanted to determine if the morphology and size of the VLPs were similar to 6 
native alphavirus particles. When viewed by transmission electron microscope (TEM), 7 
the resuspended pellet from the pRRV-GP plus CLPs transfected cells show spherical 8 
particles with a diameter of approximately 70 nm by electron microscopy (Figure 4a), 9 
consistent with native alphavirus particles.  The number of VLP observed was fewer 10 
than from a native infection.  However, the distribution of particle size and variation in 11 
particle shape was similar to what is observed when we pelleted native virus.  Some 12 
particles look less spherical in both the VLP and native virus population and we 13 
speculate this is due to pelleting virus particles.  No unenveloped CLPs (40 nm 14 
diameter, spherical particles) were observed.  No spherical particles with either 70 or 40 15 
nm diameter were found in the resuspended pellet from the control experiment where 16 
CLPs transfected into non-viral glycoprotein expressing cells. The absence of both 17 
virus-like and core-like particles in this control was consistent with a western blot of the 18 
media (Figure 3a).   19 
Cryo EM structures of both in vitro assembled CLPs (Mukhopadhyay et al., 2002) 20 
and isolated cytoplasmic nucleocapsid cores (Lamb et al., 2010) indicate that these 21 
complexes are flexible and undergo glycoprotein-mediated conformation changes.  22 
From negative stain TEM images, it was difficult to if the glycoprotein spikes were fully 23 
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covering the CLP.  To determine if there were areas on the VLP that were not 1 
surrounded by the spikes, thus the capsid proteins were exposed, we assayed 2 
resuspended VLP pellets with anti-capsid protein antibody.  The rationale was if the 3 
glycoprotein spikes were not covering the CLP then the VLP would be 4 
immunoprecipitated using an anti-capsid antibody.  However, if the CLP was covered by 5 
glycoprotein spikes, as is observed in native virus particles, then the VLPs would not 6 
bind to the capsid antibody.  Here, 20 µg of CLPs containing 48mer DNA (~1.7x1012 7 
CLPs) were transfected into 1.4x107 BHK cells, both those expressing RRV-GP and 8 
control cells not expressing viral glycoproteins.  Concentrated VLPs were 9 
immunoprecipitated with anti-capsid antibody and then analyzed by western blotting.  10 
No VLPs could be detected in the medium from RRV-GP plus CLPs transfected cells 11 
indicating large areas of capsid protein in the CLP was not surface exposed (Figure 4b, 12 
lane 3).  A strong capsid protein band was detected when we directly added 15 µg 13 
(~1.2x1012 particles) CLPs to the medium, pelleted the CLPs, and immunoprecipitated 14 
the resuspended pellet with anti-capsid antibody (Figure 4b, lane 6).  The absence of 15 
detectable capsid protein in medium from CLPs transfected into control BHK cells 16 
(Figure 4b, lane 2) demonstrated that secretion of VLPs requires glycoproteins, 17 
consistent with native alphavirus particles.   18 
 19 
VLPs can enter and disassemble in cells 20 
We tested the entry and disassembly activity of our VLPs by creating particles that 21 
contain luciferase RNA reporter.  We synthesized VLPs from CLPs containing luciferase 22 
RNA (18 µg CLPs transfected into 1.4x107 BHK cells transfected with RRV-GP or non-23 
 14 
transfected BHK control cells.  Medium containing the VLPs (total volume=3 ml) was 1 
incubated with 2.4x106 BHK cells.  After 12 hours, cells were lysed and assayed for 2 
luciferase activity.  This incubation is intended to mimic an infection; no transfection 3 
reagent was included.  Luciferase would only be translated if the VLPs could enter and 4 
disassemble within the new cell.  Within each set of experiments, the luciferase activity 5 
detected from BHK cells that were incubated with medium from pRRV-GP plus CLP-6 
transfected cells was set to 1 (Figure 5a).  Cells that were incubated with medium from 7 
CLPs transfected into BHK control cells had background levels of luminescence (Figure 8 
5a).   9 
Alphaviruses have been reported to enter the host cells either via receptor-mediated 10 
endocytosis (Bron et al., 1993; Marsh, Kielian, and Helenius, 1984).  Entry at neutral pH 11 
at the plasma membrane has also been reported (Paredes et al., 2004).  We specifically 12 
tested the hypothesis that VLPs entered BHK cells using the same route as Ross River 13 
virus.  We blocked entry using a neutralizing antibody and inhibiting pH change in the 14 
endosome. 15 
The epitope of the Ross River neutralizing antibody T10C9 is the receptor-binding 16 
domain of the E2 protein (Smith et al., 1995; Vrati et al., 1988).  When 3 ml of medium 17 
containing VLPs made with luciferase CLPs were incubated with 500 µl of T10C9 18 
antibody in serum, the luciferase activity in the incubated BHK cells was reduced by 19 
50% compared to VLPs not treated with the neutralizing antibody.  These results 20 
demonstrate that an E2-specific neutralizing antibody is able to interfere with virus-like 21 
particle entry into host cells, consistent with what is observed with native Ross River 22 
virus (Vrati et al., 1988) (Figure 5b). 23 
 15 
When BHK cells were pre-treated with NH4Cl and then infected with Ross River 1 
virus, we observed a decrease in titer from 108 to 105 pfu/ml (Figure 5b) as previously 2 
reported for other alphaviruses (Glomb-Reinmund and Kielian, 1998; Helenius, Marsh, 3 
and White, 1982).  Similarly, VLPs showed reduced luminescence in BHK cells that had 4 
been pre-treated with NH4Cl; the luciferase activity was reduced by 70% suggesting that 5 
VLP entry occurs via the endosomal pathway, where either fusion and/or core 6 
disassembly may be affected by the change in pH of the NH4Cl-incubated cell.   7 
When blocking entry of the VLPs, the luciferase activity of the cells is decreased 8 
compared to untreated VLPs but still remains higher than the background CLP 9 
luminescence value (Figure 5a, CLP).  Possible explanations could include that some 10 
VLPs do not enter cells via the receptor-mediated endosomal pathway or the 11 
arrangement of the spikes around the particle does not allow for complete neturalization 12 
by the T10C9 antibody.  In Ross River virus treated with antibody and pre-treatment of 13 
cells with NH4Cl, there was only a partial decrease in viral titer which correlates with our 14 
luciferase assay results (Figure 5b).  An alternative explanation for the luciferase 15 
activities not return to background levels is the CLP may be enveloped by any viral 16 
glycoprotein-containing membrane and, as a result, particles may show increased 17 
luminescence in cells.  To test this hypothesis, we transfected  3.6 µg (~3.1x1011 CLPs) 18 
made with Ross River capsid protein into 2.4x106 BHK cells expressing Sindbis virus 19 
glycoproteins, pSV-GP.  After the appropriate washes, medium was collected and 20 
added to 2.4x106 BHK cells.  Here, the luminescence of cells treated with medium from 21 
the RRV CLP + SV-GP VLPs was equal to background levels.  Previous reports have 22 
demonstrated that in chimera viruses where the Ross River capsid protein was 23 
 16 
exchanged with Sindbis capsid protein in a Ross River background, or Sindbis capsid 1 
protein was exchanged with a Ross River capsid protein in a Sindbis background 2 
(Lopez et al., 1994), grew very poorly or ~103 pfu/ml (Figure 5b).  Our low levels of 3 
luciferase activity are consistent with these results and suggest that VLPs are not being 4 
formed when Ross River CLPs are transfected into pSV-GP cells. 5 
 6 
 7 
Concluding remarks 8 
Animal viruses have natural and efficient entry mechanisms making them ideal 9 
vector systems for real-time imaging and drug delivery.  However, potential dangerous 10 
effects due to the presence of the parental virus genome are concerns.   In the 11 
alphavirus based VLPs, the cell entry properties associated with the glycoprotein spikes 12 
are retained but the genome and its pathogenic effects are eliminated because the 13 
cargo within the CLP is not specific to the viral genome.  We have demonstrated that 14 
VLPs can enter and disassemble within a new host cell and there is a strong correlation 15 
between the biological activity of VLPs as determined by luciferase activity and virus 16 
infectivity as determined by plaque assay. 17 
We can expand our work with Ross River VLPs to generate other alphavirus VLPs, 18 
extending specificity and cell targeting.  Many alphavirus capsid proteins form CLPs 19 
using nucleic acid (Hong, Perera, and Kuhn, 2006; Mukhopadhyay et al., 2002; 20 
Tellinghuisen et al., 1999; Tellinghuisen and Kuhn, 2000; Tellinghuisen, Perera, and 21 
Kuhn, 2001).  In addition, CLP formation using inorganic cargoes towards medical 22 
imaging has also been demonstrated (Goicochea et al., 2007).  It has been 23 
 17 
demonstrated in mice that Sindbis viral vectors specifically infect tumors because the 1 
virus particles bind to over-expressed laminin receptor synthesized in many tumors 2 
(Scheiman et al., 2010; Tseng et al., 2004), suggesting oncolytic potential for this 3 
system (Scheiman et al., 2010; Tseng et al., 2004).   4 
The enveloped VLP system provides a means to deliver toxic and labile cargoes.   5 
Toxic cargoes will only be released once the VLPs enter the target cell.  Similarly, labile 6 
cargoes are protected until they are inside the target cell.  Applications using VLPs 7 
include intracellular delivery of small molecule drugs, siRNAs of modulation of gene 8 
expression, and nanoparticles for imaging.  The VLP system will require further 9 
optimization for maximum production of VLPs and that may be specific to the cargo of 10 
the CLP.  Our results demonstrate the first steps in the use of alphavirus nanoparticles 11 
in basic mechanistic virology studies as well as in application-driven uses of the VLPs.  12 
 13 
Materials and Methods 14 
Viruses and cells 15 
The T48 strain of Ross River virus (Kuhn et al., 1991) was used in this work.  BHK-16 
21 cells (American Type Tissue Culture, Rockville, MD) were grown in minimal essential 17 
medium (MEM, Invitrogen, Carlsbad, CA) supplemented with 10% fetal bovine serum 18 
(FBS, Atlanta Biologicals, Lawrenceville, GA), non-essential amino acids,  glutamine, 19 
and penicillin/ streptomycin.  Cells were grown at 37°C in the presence of 5% CO2.  The 20 
neutralizing Ross River antibody, T10C9, was generously provided by Richard Kuhn, 21 
Purdue University. 22 
 23 
 18 
Transient expression of alphavirus glycoproteins 1 
The viral glycoproteins E3-E2-6K-E1 from Ross River virus were cloned into a 2 
pCAGGS vector; pRRV-GP.  A mutant of RRV-GP where amino acid residues E2-399-3 
401 are mutated from YAL to DDD was created by Quick Change mutagenesis 4 
(Stratagene, La Jolla, CA); pRRV-mtGP.  The viral glycoproteins E3-E2-6K-E1 from 5 
Sindbis virus were cloned into a pCAGGS vector; pSV-GP.  BHK cells were transfected 6 
with pRRV-GP/pRRV-mtGP/pSV-GP using Lipofectamine 2000 (Invitrogen), following 7 
the manufacturer’s instructions.  Viral glycoprotein expression was determined by 8 
western blotting of cell lysates and immunofluorescence assays using a polyclonal Ross 9 
River E2 or Sindbis E2 antibody (Cocalico, Reamstown, PA), and FITC- or TRITC-10 
conjugated goat anti-rabbit secondary antibody.  11 
 12 
Syncytia assays 13 
Syncytia assays were performed to determine if cells expressing pRRV-GP, pRRV-14 
mtGP, and pSV-GP were able to mediate fusion.  BHK cells were transfected with 15 
pRRV-GP, pRRV-mtGP, or pSV-GP using Lipofectamine 2000 (Invitrogen).  After fifteen 16 
hours, cells were treated with 200 µl MEM with 20 mM HEPES or 20 mM MES at the 17 
specified pH (ranging from pH 7.5 to 5) for 3 minutes at 37°C.  The medium was 18 
removed, MEM plus 10% FBS was added, and the cells were incubated for an 19 
additional 1 hour at 37°C.  Syncytia were clearly visible under bright field.  20 
 21 
Isolation of cytoplasmic cores from virus-infected cells 22 
 19 
Cytoplasmic cores were isolated as described previously (Lopez et al., 1994).  1 
Briefly, BHK cells were infected at MOI=5 with Ross River virus and 18 hours post-2 
infection cytoplasmic cores were harvested in 10 mM Tris (pH 7.5), 10 mM NaCl, and 3 
20 mM EDTA.  Lysed cells were incubated on ice for 20 minutes and then Triton X-100 4 
was added to a final concentration of 3%.  Cells were vortexed gently and then 5 
centrifuged at 4,000 x g for 10 minutes at 4°C.  Lysates were loaded on a 0-50% 6 
sucrose gradient prepared in 20 mM HEPES, 150 mM NaCl, 0.1 mM EDTA, and 0.1% 7 
TX-100 and centrifuged in a SW41 rotor at 178,000 x g for 90 minutes at 12°C (Lopez et 8 
al., 1994).  The fraction containing the nucleocapsid cores was concentrated and buffer-9 
exchanged into PBS.  Bradford assays were used to determine the concentration of the 10 
cytoplasmic cores. 11 
 12 
In vitro assembly of core-like particles 13 
Ross River capsid protein was cloned into a pET 29b vector (Novagen, EMD 14 
Chemical Inc., Gibbstown, NJ) and expressed in Rosetta2 cells (Novagen, EMD 15 
Chemical Inc.). Capsid protein purification was performed as described previously 16 
(Mukhopadhyay et al., 2002; Tellinghuisen et al., 1999).  Ross River capsid protein was 17 
concentrated and buffer exchanged into 20 mM HEPES, 150 mM NaCl, and 0.1 mM 18 
EDTA for use in CLP reactions.  For composition and morphology studies, the nucleic 19 
acid cargo was a 48mer DNA oligomer (5’-20 
CCGTTAATGCATGTCGAGATATAAAGCATAAGGGACATGCATTAACGG-3’) (IDT, 21 
Coralville, IA).  For the cell entry and disassembly studies firefly luciferase mRNA  was 22 
the cargo (Nickens and Hardy, 2008).  Capped and polyadenylated luciferase mRNA 23 
 20 
was generated by in vitro transcription using SP6 polymerase and standard reaction 1 
components (Nickens and Hardy, 2008), and was purified using an RNeasy Mini Kit 2 
(Qiagen, Valencia, CA).  Concentrations of DNA and RNA were determined using a 3 
NanoDrop 1000 (Thermo Scientific, Wilmington, DE). 4 
Ross River CLPs were assembled in vitro by incubating 100 µg capsid protein and 5 
60 µg of nucleic acid (either DNA or RNA) at room temperature for 10 minutes.  CLPs 6 
were purified to remove residual capsid protein and nucleic acid by applying the 7 
reaction mixture onto a 27% sucrose cushion (10 ml) and centrifuging at 130,000 x g for 8 
2.5 hours at 4°C.  The pellet was resuspended in PBS to give a protein concentration 9 
between 0.30-0.45 mg/ml as determined by a Bradford assay.  CLP purification yield 10 
was 35-50% of starting capsid protein.  CLP formation, both before and after 11 
concentration, was verified by an agarose gel shift assay and by TEM analysis 12 
(Mukhopadhyay et al., 2002; Tellinghuisen et al., 1999).   13 
 14 
Assembly of VLPs with CLPs 15 
The general procedure to assemble VLPs is described below.  The total amount of 16 
CLPs and the number of cells used were adjusted based on the experiment being 17 
conducted and the amount of VLPs needed for analysis.  However, the CLP:BHK cell 18 
ratio remained similar.  In most experiments, the amount of CLPs and cells used are 19 
indicated in the text.  A 35 mm dish containing 2x106 BHK cells was transfected with 20 
pRRV-GP.  Fifteen hours later, 3 µg of purified CLPs (approximately 2.6x1011 particles) 21 
were transfected into the pRRV-GP-transfected cells using 10 µl of Lipofectamine 2000.  22 
After one hour, cells were washed three times with PBS to remove residual CLPs and 23 
 21 
Lipofectamine reagent and 0.5 ml of MEM + 10% FBS were added to the cells.  After 1 
one hour additional hour, medium which contain VLPs was collected.   2 
We tested several transfection agents for transfecting CLPs including Lipofectamine 3 
2000 (Invitrogen), Fugene 6 (Roche), and PEI (Sigma).  In addition we tested reagents 4 
specific for protein and peptide transfection, including Chariot (Motif Active), and 5 
microinjection and syringe loading (Clarke and McNeil, 1992) of CLPs.  Lipofectamine 6 
2000 yielded the highest efficiency of transfection.   7 
 8 
Concentrating VLPs 9 
VLPs were concentrated for western blot and TEM studies.  Medium containing VLPs 10 
was filtered through a 0.45 µm syringe filter to remove cells and cell debris.  The 11 
medium was applied onto a 27% sucrose cushion (10 ml) and centrifuged at 130,000 x 12 
g for 2.5 hours at 4°C.  The pellet, which contains the VLPs, was resuspended in PBS 13 
to yield ~0.15 mg/ml of VLPs based on protein concentration.   14 
 15 
Western blot and immunoprecipitation of VLPs 16 
To determine the composition of VLPs, 10 µl of the resuspended VLPs was 17 
analyzed by SDS-PAGE and probed for RRV capsid and E2 protein using polyclonal 18 
antibodies.  For immunoprecipitation experiments, anti-capsid protein antibodies were 19 
coupled to the agarose coupling resin columns of a ProFound Co-Immunoprecipitation 20 
Kit (Pierce, Rockford, IL) according to the manufacturer’s protocol.  As a control for non-21 
specific binding of CLPs/protein to the agarose beads, a sample not including antibody 22 
was also performed.  Ten microliters of the resuspended VLPs were incubated with the 23 
 22 
agarose beads (+/-antibody) at room temperature for two hours.  Samples were eluted 1 
from the column by SDS and analyzed by western blotting. 2 
 3 
Transmission electron microscopy 4 
Samples of concentrated VLPs (3-5 µl) were applied to 400-mesh carbon-coated 5 
formvar copper grids and stained with 1% uranyl acetate.  The grids were examined on 6 
a JEOL 1010 transmission electron microscope (Tokyo, Japan) at 80 kV.  Images were 7 
recorded using a Gatan UltraScan 4000 CCD camera (Pleasanton, CA).   8 
 9 
Luciferase assay  10 
VLPs containing luciferase RNA were added to cells to determine if they were 11 
capable of entering and disassembling within a cell.  Medium containing VLPs from 6-35 12 
mm dishes were collected (total volume=3 ml) and incubated with 2.4x106 BHK cells.  13 
After 12 hours, luciferase assays were performed using a Luciferase Assay Kit (Sigma, 14 
St. Louis, MO) according to the manufacturer’s directions.  Cells were lysed in 150 µl 15 
lysis buffer.  Samples were measured using a BIO-TEK synergy HT multimode 16 
microplate reader (BIO-TEK, Winooski, VT). Samples were measured in triplicate and at 17 
least six experiments were averaged for each sample.   18 
The range of luminescence minimum and maximum between experiments varied 19 
even though the relative values within an experiment were consistent.  The absolute 20 
luminescence values were normalized for each experiment.  To do so, background 21 
values determined from BHK cell lysates was subtracted from all samples.  Within each 22 
set of experiments, luminescence from particles isolated from cells expressing RRV-GP 23 
 23 
that had been transfected with CLPs (medium containing VLPs) was set to 1.  Standard 1 
error was determined between sets of experiments. 2 
 3 
Treatment of VLPs and virus with neutralizing antibody  4 
Three milliliters of medium from containing VLPs were incubated with 500 µl T10C9 5 
antibody in serum for 30 minutes at room temperature.  The mixture was applied to BHK 6 
cells and after 12 hours luciferase activity was determined as described above.  One 7 
milliliter of wild-type Ross River virus was incubated with 500 ml of T10C9 antibody for 8 
30 minutes at room temperature.  Infectivity was determined by plaque asay. 9 
 10 
Treatment of cells with ammonium chloride  11 
BHK cells were pre-treated with 20mM freshly prepared ammonium chloride for 20 12 
minutes before being incubated with 3 ml of VLPs.  After one hour of incubation, the 13 
medium containing the particles were removed and fresh medium containing 20mM 14 
ammonium chloride was added.  After 12 hours, cell lysates were assayed for luciferase 15 
activity.  Infectivity of Ross River virus was determined in a similar manner.  Cells were 16 
pre-treated with 20 mM NH4Cl for 20 minutes before being infected with Ross River 17 
virus.  After 24 hours, medium from virus-incubated cells were removed after and 18 
titered.   19 
 20 
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Figure legends 1 
Figure 1.  Purified core-like particles and cytoplasmic cores.  Purified core-like 2 
particles containing recombinant Ross River capsid protein and (a) 48mer DNA 3 
oligomer and (b) luciferase RNA are shown in negative stain TEM images.  Purified 4 
cytoplasmic cores isolated from BHK infected with Ross River virus are shown in (c).  5 
Core-like particles (a and b) and cytoplasmic nucleocapsid cores (c) are 40 nm in 6 
diameter and are homogeneous, spherical particles. (d)  Expression of viral 7 
glycoproteins from pRRV-GP-, pRRV-mtGP-, and pSV-GP-transfected cells.  Cells were 8 
transfected with pRRV-GP, pRRV-mtGP, or pSV-GP for 15 hours and then fixed with 9 
1.5% paraformaldehyde in PBS before being treated with RRV E2 (pRRV-GP and 10 
pRRV-mtGP) or Sindbis E2 (pSV-GP) antibody.  Untreated cells (Mock) and virus-11 
infected cells (RRV infection and Sindbis infection) were used as negative and positive 12 
controls, respectively.  All panels were stained with TRITC-conjugated Goat anti-rabbit 13 
secondary except RRV infection which was treated with FITC-conjugated secondary 14 
antibody. Cells were imaged at 20x magnification on an Olympus 1X71 fluorescence 15 
microscope. 16 
 17 
Figure 2.  Timing of virus-like particle production.  (a)  Time course for core-like 18 
particle transfection.  BHK cells (2.4x106) were transfected with CLPs containing 48mer 19 
DNA oligomer (3 µg, 2.6x1011 particles) and after the indicated time, cells were washed 20 
to remove non-transfected CLPs, and then lysed.  Cell lysates were run on a SDS-21 
PAGE and probed for capsid protein.  Each data point represents a separate 22 
transfection.  (b)  Time course for release of VLPs.  BHK cells transfected with pRRV-23 
 29 
GP (1.4x107 cells) were transfected with CLPs containing 48mer DNA oligomer (19 µg, 1 
1.6x1012 particles).  After one hour, cells were washed and new medium was added.  2 
After one additional hour, medium was collected (9 ml) at different times, centrifuged, 3 
and the pellet probed for capsid protein.  Zero time is defined as immediately after 4 
washing cells and adding fresh media.  At 30 min medium contains VLPs released 5 
between 0 and 30 min.  Similarly 60 min and 120 min correspond to collecting VLPs 6 
released between 30 and 60 minutes and 60 and 120 minutes after adding medium, 7 
respectively.  The absence of capsid protein at zero time indicates that the washing step 8 
removed all non-transfected CLPs.  Far left lane is a positive control of purified capsid 9 
protein. 10 
 11 
Figure 3.  Viral protein components of VLPs.  (a) Western blot analysis of pelleted 12 
VLPs.  Medium containing VLPs (made from 90 µg CLPs containing 48mer DNA 13 
oligomer transfected into pRRV-GP-tranfected cells) was centrifuged.  Pellets were 14 
resuspended in ~50 µl PBS to yield 0.15 mg/ml of VLPs. Ten µl of pelleted VLPs were 15 
probed for E2 and capsid protein.  Native Ross River virus was used as a control (lane 16 
2).  (b)  VLPs production reduced with pRRV-mtGP.  BHK cells were transfected with 17 
pRRV-mtGP and 108 µg CLPs containing 48mer DNA oligomer.  Medium was collected, 18 
centrifuged, and the pellet probed for E2 and capsid protein.  Native Ross River virus 19 
was pelleted as a control.  Lane 1 contains 1x108 Ross River virus particles.   20 
 21 
Figure 4. Morphology of VLPs.  (a) TEM images of VLPs.  Concentrated VLPs were 22 
stained with uranyl acetate and visualized by TEM.  A sample of Ross River virus 23 
 30 
prepared the same way is also shown.  (b)  VLPs are covered by viral glycoproteins.  1 
Immunoprecipitation experiments were performed on concentrated VLPs using anti-2 
capsid antibody.  Twenty µl of resuspended pelleted VLPs (~3 µg) were added to beads 3 
alone (- antibody) or beads coupled with capsid protein antibody (+ antibody).  No 4 
capsid protein was detected (lane 3, pRRV-GP + CLPs).  No capsid protein was 5 
detected in pellets from medium of CLPs transfected into control BHK cells (lane 2, BHK 6 
+ CLPs).  The positive control of CLPs containing 48mer DNA (18 µg, ~1.6x1012 CLPs) 7 
added to the medium of BHK cells showed a strong band corresponding to capsid 8 
protein in lane 6 (Media + CLPs), demonstrating that CLPs can be detected in growth 9 
medium.  Purified capsid protein is shown in lane 1 as a control. 10 
 11 
Figure 5.  Biological activity of VLPs and Infectivity of virus.  (a) Biological activity 12 
of VLPs.  VLPs containing Ross River capsid protein and luciferase RNA were made 13 
and 3 ml of the preparation were incubated with BHK cells (2.4x105) for one hour.  After 14 
12 hours, the cells were lysed and assayed for luciferase activity.  Within each set of 15 
experiments, luminescence values from cells incubated with medium from cells 16 
transfected with pRRV-GP and CLPs were normalized to 1 (VLP) since the minimum 17 
and maximum luminescence varied between experiments.  Cells were incubated with 18 
medium from BHK cells transfected with CLPs only (CLP).  VLPs were incubated with 19 
the Ross River neutralizing antibody, T10C9, for 30 minutes at room temperature before 20 
being added to BHK cells (VLP + antibody).  BHK cell were pre-treated with NH4Cl 21 
before addition of VLPs (VLP+ NH4Cl).  VLPs from CLPs containing luciferase RNA 22 
were transfected into BHK expressing pSV-GP were collected and used to infect BHK 23 
 31 
cells (RRV CLP+ pSV-GP).  (b)  Ross River virus infectivity.  Infectivity of Ross River 1 
virus alone (WT RRV), in the presence of T10C9 neutralizing antibody (RRV + 2 
antibody), and after being amplified in the presence of ammonium chloride (RRV + 3 
NH4Cl).   The titer from the chimera virus, SIN(RRc), which contains Ross River capsid 4 
protein in a Sindbis background is taken directly from Lopez et al.  The virus “CP” is a 5 
replicon derivative that contains only the non-structural proteins and the capsid protein.  6 
The average of two experiments for CP, RRV+antibody, and RRV+NH4Cl is shown.  7 
Panels (a) and (b) are only to show trends in the data and cannot be directly compared.   8 
 9 
 10 
 11 
